| |
|
|
| Name: |
EcoR1 Capital LLC |
| City: |
San Francisco |
| State: |
CA |
| Zip: |
94158 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
65 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
APLS |
Apellis Pharmaceuticals Inc |
1 |
- |
$42.56 |
$667,589,000 |
11,357,425 |
16.95% |
-1,231,000 |
184,357 |
9.922 |
N/A |
|
|
PRTA |
Prothena Corp Plc |
2 |
- |
$21.65 |
$286,943,000 |
11,584,280 |
7.29% |
-134,030,000 |
0 |
21.568 |
N/A |
|
|
ARVN |
Arvinas Holding Company, Llc |
3 |
- |
$34.65 |
$277,670,000 |
6,726,491 |
7.05% |
808,000 |
0 |
9.779 |
N/A |
|
|
SRPT |
Sarepta Therapeutics Inc |
4 |
- |
$129.12 |
$248,542,000 |
1,919,835 |
6.31% |
168,225,000 |
1,086,928 |
2.28 |
Drug Manufacturers - ... |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
5 |
- |
$49.50 |
$194,513,000 |
4,155,375 |
4.94% |
122,908,000 |
2,142,858 |
5.654 |
N/A |
|
|
GLPG |
Galapagos NV - ADR |
6 |
- |
$28.38 |
$185,352,000 |
5,756,268 |
4.71% |
-48,640,000 |
0 |
8.81 |
N/A |
|
|
ANAB |
Anaptysbio Inc |
7 |
- |
$23.95 |
$169,373,000 |
7,521,024 |
4.3% |
8,273,000 |
0 |
23.648 |
N/A |
|
|
ZYME |
Zymeworks Inc |
8 |
- |
$8.91 |
$141,362,000 |
13,437,473 |
3.59% |
1,747,000 |
0 |
19.194 |
N/A |
|
|
KURA |
Kura Oncology Inc |
9 |
- |
$22.11 |
$123,861,000 |
5,806,871 |
3.14% |
40,358,000 |
0 |
6.933 |
N/A |
|
|
JAZZ |
Jazz Pharmaceuticals Inc |
10 |
- |
$109.27 |
$122,100,000 |
1,013,952 |
3.1% |
-2,616,000 |
0 |
1.658 |
Biotechnology |
|
|
XNCR |
Xencor Inc |
11 |
- |
$23.77 |
$117,962,000 |
5,330,416 |
3% |
5,814,000 |
47,900 |
8.03 |
Biotechnology |
|
|
ACAD |
Acadia Pharmaceuticals Inc |
12 |
- |
$15.27 |
$110,782,000 |
5,991,479 |
2.81% |
-76,811,000 |
0 |
3.727 |
Biotechnology |
|
|
TNGX |
Tango Therapeutics Ord Shs |
13 |
- |
$0.00 |
$105,846,000 |
13,330,736 |
2.69% |
-26,128,000 |
0 |
13.071 |
N/A |
|
|
IMNM |
Immunome Inc. |
14 |
- |
$13.65 |
$95,744,000 |
3,879,415 |
2.43% |
54,234,000 |
0 |
6.969 |
N/A |
|
|
CRSP |
Crispr Therapeutics Ag |
15 |
New |
$54.76 |
$94,693,000 |
1,389,276 |
2.4% |
94,693,000 |
1,389,276 |
1.966 |
N/A |
|
|
MRSN |
Mersana Therapeutics, Inc. |
16 |
- |
$2.62 |
$86,754,000 |
19,364,688 |
2.2% |
41,828,000 |
0 |
16.06 |
N/A |
|
|
MORF |
Morphic Holding, Inc. |
17 |
- |
$29.49 |
$83,930,000 |
2,384,384 |
2.13% |
77,829,000 |
2,173,122 |
4.794 |
N/A |
|
|
NUVB |
Nuvation Bio Ord Shs Class A |
18 |
- |
$10.42 |
$69,923,000 |
19,209,643 |
1.78% |
40,916,000 |
0 |
8.867 |
N/A |
|
|
NGNE |
Neurogene |
19 |
- |
$3.68 |
$64,711,000 |
1,271,342 |
1.64% |
40,072,000 |
0 |
3.035 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
20 |
- |
$0.00 |
$63,492,000 |
5,618,779 |
1.61% |
18,767,000 |
0 |
6.427 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
21 |
- |
$0.00 |
$46,998,000 |
3,418,068 |
1.19% |
15,552,000 |
0 |
5.098 |
N/A |
|
|
ADAP |
Adaptimmune Therapeutics PLC |
22 |
New |
$1.08 |
$43,298,000 |
27,404,070 |
1.1% |
43,298,000 |
27,404,070 |
17.719 |
N/A |
|
|
TCRX |
Tscan Therapeutics, Inc. |
23 |
- |
$0.00 |
$39,700,000 |
5,000,000 |
1.01% |
10,550,000 |
0 |
11.481 |
N/A |
|
|
VYGR |
Voyager Therapeutics, Inc. |
24 |
- |
$8.44 |
$36,472,000 |
3,917,546 |
0.93% |
3,965,000 |
66,039 |
10.455 |
N/A |
|
|
THRD |
Third Harmonic Bio, Inc. |
25 |
- |
$15.54 |
$30,042,000 |
3,182,444 |
0.76% |
-4,869,000 |
0 |
7.85 |
N/A |
|
|
NMRA |
Neumora Therapeutics, Inc. |
26 |
- |
$9.45 |
$28,482,000 |
2,071,450 |
0.72% |
-6,836,000 |
0 |
1.357 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
27 |
New |
$37.67 |
$27,281,000 |
650,000 |
0.69% |
27,281,000 |
650,000 |
1.033 |
Diagnostic Substances |
|
|
ITOS |
Iteos Therapeutics, Inc. |
28 |
- |
$0.00 |
$27,270,000 |
1,999,249 |
0.69% |
15,061,000 |
884,227 |
5.267 |
N/A |
|
|
LENZ |
Lenz Therapeutics |
29 |
- |
$18.64 |
$27,238,000 |
1,219,774 |
0.69% |
4,867,000 |
-7,318,672 |
4.777 |
N/A |
|
|
AVIR |
Atea Pharmaceuticals, Inc. |
30 |
- |
$0.00 |
$24,829,000 |
6,145,861 |
0.63% |
3,492,000 |
-850,000 |
7.439 |
N/A |
|
|
ALEC |
Alector, Inc. |
31 |
- |
$5.39 |
$24,420,000 |
4,056,548 |
0.62% |
-7,951,000 |
0 |
5.119 |
N/A |
|
|
EWTX |
Edgewise Therapeutics, Inc. |
32 |
- |
$0.00 |
$22,807,000 |
1,250,385 |
0.58% |
-15,409,000 |
-2,242,809 |
1.355 |
N/A |
|
|
NKTX |
Nkarta, Inc. |
33 |
New |
$0.00 |
$21,620,000 |
2,000,000 |
0.55% |
21,620,000 |
2,000,000 |
4.11 |
N/A |
|
|
PHVS |
Pharvaris N V Ord Shs |
34 |
- |
$0.00 |
$20,799,000 |
900,000 |
0.53% |
-4,446,000 |
0 |
2.173 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
35 |
New |
$0.00 |
$20,493,000 |
300,000 |
0.52% |
20,493,000 |
300,000 |
0.278 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
36 |
New |
$242.49 |
$20,028,000 |
75,000 |
0.51% |
20,028,000 |
75,000 |
0.38 |
Diagnostic Substances |
|
|
RNA |
Avidity Biosciences, Inc. |
37 |
New |
$29.51 |
$19,333,000 |
757,576 |
0.49% |
19,333,000 |
757,576 |
0.953 |
N/A |
|
|
OVID |
Ovid Therapeutics Inc. |
38 |
- |
$3.11 |
$18,658,000 |
6,117,400 |
0.47% |
-1,040,000 |
0 |
9.643 |
N/A |
|
|
VERV |
Verve Therapeutics, Inc. |
39 |
- |
$0.00 |
$16,600,000 |
1,250,000 |
0.42% |
-825,000 |
0 |
1.554 |
N/A |
|
|
KROS |
Keros Therapeutics, Inc. |
40 |
New |
$0.00 |
$12,413,000 |
187,500 |
0.32% |
12,413,000 |
187,500 |
0.552 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
41 |
New |
$32.63 |
$12,124,000 |
427,039 |
0.31% |
12,124,000 |
427,039 |
0.526 |
N/A |
|
|
KYTX |
Kyverna Therapeutics |
42 |
New |
$13.70 |
$11,178,000 |
450,000 |
0.28% |
11,178,000 |
450,000 |
1.047 |
N/A |
|
|
GOSS |
Gossamer Bio Inc |
43 |
- |
$0.67 |
$10,851,000 |
9,195,404 |
0.28% |
2,460,000 |
0 |
4.079 |
N/A |
|
|
ALVR |
Allovir Inc |
44 |
New |
$0.80 |
$8,526,000 |
11,294,585 |
0.22% |
8,526,000 |
11,294,585 |
18.318 |
N/A |
|
|
KOD |
Kodiak Sciences Inc. |
45 |
New |
$3.21 |
$8,488,000 |
1,613,600 |
0.22% |
8,488,000 |
1,613,600 |
3.602 |
N/A |
|
|
GBIO |
Generation Bio Co. |
46 |
- |
$0.00 |
$8,331,000 |
2,046,867 |
0.21% |
4,954,000 |
0 |
3.445 |
N/A |
|
|
ATRA |
Atara Biotherapeutics, Inc. |
47 |
- |
$0.69 |
$7,056,000 |
10,167,043 |
0.18% |
1,894,000 |
100,000 |
9.356 |
N/A |
|
|
PRQR |
ProQR Therapeutics N.V. |
48 |
- |
$1.90 |
$6,605,000 |
2,884,357 |
0.17% |
705,000 |
-95,659 |
5.753 |
N/A |
|
|
ALGS |
Aligos Therapeutics, Inc. |
49 |
- |
$0.00 |
$6,262,000 |
6,389,468 |
0.16% |
2,019,000 |
0 |
8.873 |
N/A |
|
|
ARQT |
Arcutis Biotherapeutics, Inc. |
50 |
New |
$9.48 |
$4,955,000 |
500,000 |
0.13% |
4,955,000 |
500,000 |
0.47 |
N/A |
|
|
PRME |
Prime Medicine, Inc. |
51 |
- |
$8.03 |
$4,900,000 |
700,000 |
0.12% |
4,900,000 |
700,000 |
0.72 |
N/A |
|
|
NUVB.WS |
Nuvation Equity Warrants Ex... |
52 |
- |
$0.00 |
$3,507,000 |
963,333 |
0.09% |
2,052,000 |
0 |
10.704 |
N/A |
|
|
HOOK |
Hookipa Pharma Inc. |
53 |
- |
$0.00 |
$3,272,000 |
4,595,024 |
0.08% |
-450,000 |
0 |
9.031 |
N/A |
|
|
SRZNW |
Surrozen Equity Warrant Exp... |
54 |
- |
$0.00 |
$1,047,000 |
66,665 |
0.03% |
420,000 |
0 |
0.741 |
N/A |
|
|
PMVP |
Pmv Pharmaceuticals, Inc. |
55 |
- |
$0.00 |
$964,000 |
566,879 |
0.02% |
-793,000 |
0 |
1.042 |
N/A |
|
|
CMAXW |
Caremax Equity Warrant Exp ... |
56 |
- |
$0.00 |
$482,000 |
100,000 |
0.01% |
432,000 |
0 |
0.111 |
N/A |
|
|
ALPN |
Alpine Immune Sciences Inc |
57 |
New |
$64.97 |
$40,000 |
1,000 |
0% |
40,000 |
1,000 |
0.002 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
61 |
Closed |
$0.60 |
$0 |
0 |
0% |
-19,090,000 |
-887,076 |
0 |
N/A |
|
|
ARGX |
Argenx Se |
60 |
Closed |
$356.66 |
$0 |
0 |
0% |
-114,508,000 |
-300,997 |
0 |
N/A |
|
|
PHAT |
Phathom Pharmaceuticals, Inc. |
65 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,812,000 |
-198,480 |
0 |
N/A |
|
|
ALLK |
Allakos Inc. |
59 |
Closed |
$1.43 |
$0 |
0 |
0% |
-2,044,000 |
-748,900 |
0 |
N/A |
|
|
NGM |
Ngm Biopharmaceuticals Inc |
64 |
Closed |
$1.54 |
$0 |
0 |
0% |
-2,049,000 |
-2,385,873 |
0 |
N/A |
|
|
MRTX |
Mirati Therapeutics, Inc. |
58 |
Closed |
$58.70 |
$0 |
0 |
0% |
-434,573,000 |
-7,396,979 |
0 |
Biotechnology |
|
|
RVMD |
Revolution Medicines, Inc. |
63 |
Closed |
$39.66 |
$0 |
0 |
0% |
-3,802,000 |
-132,579 |
0 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
62 |
Closed |
$0.00 |
$0 |
0 |
0% |
-1,898,000 |
-137,014 |
0 |
N/A |
|
